CRYO CELL INTERNATIONAL INC Logo

CRYO CELL INTERNATIONAL INC

Cryopreserves newborn cord blood and tissue stem cells for expectant families.

CCEL | NYSE

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
United States of America
Address:
700 BROOKER CREEK BLVD, 34677 OLDSMAR
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Cryo-Cell International, Inc., established in 1989, is the world's first private cord blood bank. The company provides premier cryopreservation services for umbilical cord blood and cord tissue stem cells. Its core business involves the collection, processing, and long-term cryogenic storage of these cells for exclusive family use. These stem cells can be used to treat numerous diseases and conditions, with ongoing research expanding their potential applications in regenerative medicine. Trusted by over 500,000 parents globally, Cryo-Cell utilizes advanced processing technologies and a proprietary five-chamber storage bag to ensure the long-term viability and multiple treatment opportunities from a single collection. The company's target market consists of expectant families seeking to preserve their newborn's stem cells for future health needs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all CRYO CELL INTERNATIONAL INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CRYO CELL INTERNATIONAL INC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CRYO CELL INTERNATIONAL INC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
AngioLab, Inc. Logo
Develops anti-angiogenic therapeutics and foods for angiogenesis-related diseases.
South Korea 251280
Anixa Biosciences Inc Logo
Clinical-stage biotech developing CAR-T immunotherapies and vaccines to fight cancer.
United States of America ANIX
Annovis Bio, Inc. Logo
Developing oral therapies for neurodegenerative diseases like Alzheimer's and Parkinson's.
United States of America ANVS
Aoyama Zaisan Networks Company,Limited Logo
Consulting on inheritance and business succession for individuals and corporations.
Japan 8929
APG SGA SA Logo
Switzerland's leading OOH media firm offering digital and analogue outdoor advertising solutions.
Switzerland APGN.SW
Biotech R&D using a miniature pig model, offering CRO services and biomaterials to pharma.
South Korea 149300
ARM HOLDINGS PLC /UK Logo
Licenses energy-efficient CPU IP for AI, mobile, automotive, IoT, and cloud markets.
United States of America ARM
Arterra Bioscience Logo
Develops natural active ingredients via biotechnology for cosmetic, pharma, and food sectors.
Italy ABS
ARVINAS, INC. Logo
Develops protein degradation drugs for oncology & neuroscience, targeting undruggable proteins.
United States of America ARVN
ASUA Inc. Logo
Consulting and solutions provider enhancing logistics safety and efficiency with IoT and telecom.
Japan 246A

Talk to a Data Expert

Have a question? We'll get back to you promptly.